These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35473737)

  • 1. Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study).
    Haroon S; Nirantharakumar K; Hughes SE; Subramanian A; Aiyegbusi OL; Davies EH; Myles P; Williams T; Turner G; Chandan JS; McMullan C; Lord J; Wraith DC; McGee K; Denniston AK; Taverner T; Jackson LJ; Sapey E; Gkoutos G; Gokhale K; Leggett E; Iles C; Frost C; McNamara G; Bamford A; Marshall T; Zemedikun DT; Price G; Marwaha S; Simms-Williams N; Brown K; Walker A; Jones K; Matthews K; Camaradou J; Saint-Cricq M; Kumar S; Alder Y; Stanton DE; Agyen L; Baber M; Blaize H; Calvert M
    BMJ Open; 2022 Apr; 12(4):e060413. PubMed ID: 35473737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-pharmacological therapies for postviral syndromes, including Long COVID: a systematic review and meta-analysis protocol.
    Chandan JS; Brown K; Simms-Williams N; Camaradou J; Bashir N; Heining D; Aiyegbusi OL; Turner G; Cruz Rivera S; Hotham R; Nirantharakumar K; Sivan M; Khunti K; Raindi D; Marwaha S; Hughes SE; McMullan C; Calvert M; Haroon S
    BMJ Open; 2022 Apr; 12(4):e057885. PubMed ID: 35410933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise-CISCO-21.
    Morrow A; Gray SR; Bayes HK; Sykes R; McGarry E; Anderson D; Boiskin D; Burke C; Cleland JGF; Goodyear C; Ibbotson T; Lang CC; McConnachie ; Mair F; Mangion K; Patel M; Sattar N; Taggart D; Taylor R; Dawkes S; Berry C
    Trials; 2022 Aug; 23(1):660. PubMed ID: 35971155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, pathophysiology, prediction and health-related quality of life of long COVID: study protocol of the longitudinal multiple cohort CORona Follow Up (CORFU) study.
    Ghossein-Doha C; Wintjens MSJN; Janssen EBNJ; Klein D; Heemskerk SCM; Asselbergs FW; Birnie E; Bonsel GJ; van Bussel BCT; Cals JWL; Ten Cate H; Haagsma J; Hemmen B; van der Horst ICC; Kietselaer BLJH; Klok FA; de Kruif MD; Linschoten M; van Santen S; Vernooy K; Willems LH; Westerborg R; Warle M; van Kuijk SMJ
    BMJ Open; 2022 Nov; 12(11):e065142. PubMed ID: 36446465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): Rasch analysis.
    Hughes SE; Haroon S; Subramanian A; McMullan C; Aiyegbusi OL; Turner GM; Jackson L; Davies EH; Frost C; McNamara G; Price G; Matthews K; Camaradou J; Ormerod J; Walker A; Calvert MJ
    BMJ; 2022 Apr; 377():e070230. PubMed ID: 35477524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium.
    Daynes E; Baldwin M; Greening NJ; Yates T; Bishop NC; Mills G; Roberts M; Hamrouni M; Plekhanova T; Vogiatzis I; Echevarria C; Nathu R; McAuley HJC; Latimer L; Glennie J; Chambers F; Penfold R; Hume E; Megaritis D; Alexiou C; Potthoff S; Hogg MJ; Haighton C; Nichol B; Leavy OC; Richardson M; Elneima O; Singapuri A; Sereno M; Saunders RM; Harris VC; Nolan CM; Bolton C; Houchen-Wolloff L; Harrison EM; Lone N; Quint J; Chalmers JD; Ho LP; Horsley A; Marks M; Poinasamy K; Ramen B; Wain LV; Brightling C; Man WD; Evans R; Singh SJ
    Trials; 2023 Jan; 24(1):61. PubMed ID: 36703183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT).
    Herrett E; Tomlin K; Lin LY; Tomlinson LA; Jit M; Briggs A; Marks M; Sandmann F; Parry J; Bates C; Morley J; Bacon S; Butler-Cole B; Mahalingasivam V; Dennison A; Smith D; Gabriel E; Mehrkar A; Goldacre B; Smeeth L; Eggo RMM
    BMJ Open; 2023 Feb; 13(2):e071261. PubMed ID: 36806073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deriving and validating a risk prediction model for long COVID-19: protocol for an observational cohort study using linked Scottish data.
    Daines L; Mulholland RH; Vasileiou E; Hammersley V; Weatherill D; Katikireddi SV; Kerr S; Moore E; Pesenti E; Quint JK; Shah SA; Shi T; Simpson CR; Robertson C; Sheikh A
    BMJ Open; 2022 Jul; 12(7):e059385. PubMed ID: 35793922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-designing personalised self-management support for people living with long Covid: The LISTEN protocol.
    Heaton-Shrestha C; Torrens-Burton A; Leggat F; Islam I; Busse M; Jones F
    PLoS One; 2022; 17(10):e0274469. PubMed ID: 36219596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for palliative symptom control in COVID-19 patients.
    Andreas M; Piechotta V; Skoetz N; Grummich K; Becker M; Joos L; Becker G; Meissner W; Boehlke C
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD015061. PubMed ID: 34425019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial.
    Kjellberg A; Abdel-Halim L; Hassler A; El Gharbi S; Al-Ezerjawi S; Boström E; Sundberg CJ; Pernow J; Medson K; Kowalski JH; Rodriguez-Wallberg KA; Zheng X; Catrina S; Runold M; Ståhlberg M; Bruchfeld J; Nygren-Bonnier M; Lindholm P
    BMJ Open; 2022 Nov; 12(11):e061870. PubMed ID: 36323462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and cost-effectiveness of a personalised self-management intervention for living with long COVID: protocol for the LISTEN randomised controlled trial.
    Potter C; Leggat F; Lowe R; Pallmann P; Riaz M; Barlow C; Edwards A; Siriwardena AN; Sevdalis N; Sewell B; McRae J; Fish J; de Sousa de Abreu MI; Jones F; Busse M
    Trials; 2023 Feb; 24(1):75. PubMed ID: 36726167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol.
    Mera-Cordero F; Bonet-Monne S; Almeda-Ortega J; García-Sangenís A; Cunillera-Puèrtolas O; Contreras-Martos S; Alvarez-Muñoz G; Monfà R; Balanzo-Joué M; Morros R; Salvador-Gonzalez B
    Trials; 2022 Jan; 23(1):19. PubMed ID: 34991703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STIMULATE-ICP-CAREINEQUAL (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways) study protocol: Defining usual care and examining inequalities in Long Covid support.
    Ramasawmy M; Mu Y; Clutterbuck D; Pantelic M; Lip GYH; van der Feltz-Cornelis C; Wootton D; Williams NH; Montgomery H; Mallinson Cookson R; Attree E; Gabbay M; Heightman M; Alwan NA; Banerjee A; Lorgelly P;
    PLoS One; 2022; 17(8):e0271978. PubMed ID: 35969597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.